| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 10 4917-4925, Copyright © 1995 by American Association of Immunologists
ARTICLES |
PA Kiener, P Moran-Davis, BM Rankin, AF Wahl, A Aruffo and D Hollenbaugh
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121, USA.
CD40 is a glycoprotein of about 50 kDa that plays a crucial role in B cell growth and differentiation. It is found on the surface of B cells, follicular dendritic cells, monocytes, and some endothelial, epithelial, and carcinoma cells. Engagement of CD40 with anti-CD40 mAbs, gp39 expressed on the cell surface or soluble forms of gp39, primes B cells to efficiently respond to subsequent stimulatory signals leading to B cell proliferation, differentiation, and isotype switching. Peripheral monocytes also express CD40 on the cell surface and expression in increased following treatment with IFN-gamma. Using a soluble murine CD8/human gp39 fusion protein (sgp39) we have found that CD40 plays a crucial role in the regulation of monocyte function. Stimulation of human peripheral monocytes with sgp39 induced homotypic aggregation and significantly increased the expression of several cell- surface proteins including CD54, MHC class II, CD86, and CD40. Soluble gp39 also dramatically enhanced monocyte survival, preventing the onset of apoptosis that normally occurs upon withdrawal of serum. Finally, in the absence of any costimulatory molecules, sgp39 stimulated monocytes to produce TNF-alpha, IL-1 beta, IL-6, and IL-8. These results suggest that ligation of CD40 on human monocytes induces phenotypic changes that would be expected to influence T cell activation by the monocyte and also to enhance or prolong inflammatory responses.
This article has been cited by other articles:
|
|
 |
|
  A. Sinistro, C. Almerighi, C. Ciaprini, S. Natoli, E. Sussarello, S. Di Fino, F. Calo-Carducci, G. Rocchi, and A. Bergamini Downregulation of CD40 Ligand Response in Monocytes from Sepsis Patients Clin. Vaccine Immunol., December 1, 2008; 15(12): 1851 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Stevenson, E. C. Crossley, N. Thirumalapura, D. H. Walker, and N. Ismail Regulatory Roles of CD1d-Restricted NKT Cells in the Induction of Toxic Shock-Like Syndrome in an Animal Model of Fatal Ehrlichiosis Infect. Immun., April 1, 2008; 76(4): 1434 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nolan, M. Weiden, A. Kelly, Y. Hoshino, S. Hoshino, N. Mehta, and J. A. Gold CD40 and CD80/86 Act Synergistically to Regulate Inflammation and Mortality in Polymicrobial Sepsis Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 301 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Duygu, V. Barisik, H. Kurt, U. Turk, E. Ercan, and S. Kose Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation Europace, February 1, 2008; 10(2): 210 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Leveille, M. Bouillon, W. Guo, J. Bolduc, E. Sharif-Askari, Y. El-Fakhry, C. Reyes-Moreno, R. Lapointe, Y. Merhi, J. A. Wilkins, et al. CD40 Ligand Binds to {alpha}5beta1 Integrin and Triggers Cell Signaling J. Biol. Chem., February 23, 2007; 282(8): 5143 - 5151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Yu, E. M. C. Chow, H. Wong, J. Gu, O. Mandelboim, S. D. Gray-Owen, and M. A. Ostrowski CEACAM1 (CD66a) Promotes Human Monocyte Survival via a Phosphatidylinositol 3-Kinase- and AKT-dependent Pathway J. Biol. Chem., December 22, 2006; 281(51): 39179 - 39193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Hewitson, G. R. Jenkins, P. A. Hamblin, and A. P. Mountford CD40/CD154 Interactions Are Required for the Optimal Maturation of Skin-Derived APCs and the Induction of Helminth-Specific IFN-{gamma} but Not IL-4. J. Immunol., September 1, 2006; 177(5): 3209 - 3217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Chen, H.-W. Chang, C.-J. Wu, C.-H. Yang, W. C. Hung, K.-H. Yeh, and M. Fu Percutaneous Transluminal Mitral Valvuloplasty Reduces Circulating Soluble CD40 Ligand in Rheumatic Mitral Stenosis Chest, July 1, 2005; 128(1): 36 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Jacobson, E. Concepcion, T. Oashi, and Y. Tomer A Graves' Disease-Associated Kozak Sequence Single-Nucleotide Polymorphism Enhances the Efficiency of CD40 Gene Translation: A Case for Translational Pathophysiology Endocrinology, June 1, 2005; 146(6): 2684 - 2691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Bavendiek, A. Zirlik, S. LaClair, L. MacFarlane, P. Libby, and U. Schonbeck Atherogenesis in Mice Does Not Require CD40 Ligand From Bone Marrow-Derived Cells Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1244 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Liu, J. L. Arbiser, A. Holmgren, G. Klein, and E. Klein PSK and Trx80 inhibit B-cell growth in EBV-infected cord blood mononuclear cells through T cells activated by the monocyte products IL-15 and IL-12 Blood, February 15, 2005; 105(4): 1606 - 1613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Stephens, Y. Yan, M. Jandrot-Perrus, J.-L. Villeval, K. J. Clemetson, and D. R. Phillips Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen Blood, January 1, 2005; 105(1): 186 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Seshasayee, H. Wang, W. P. Lee, P. Gribling, J. Ross, N. Van Bruggen, R. Carano, and I. S. Grewal A Novel in Vivo Role for Osteoprotegerin Ligand in Activation of Monocyte Effector Function and Inflammatory Response J. Biol. Chem., July 16, 2004; 279(29): 30202 - 30209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. I. Furman, L. A. Krueger, M. D. Linden, M. R. Barnard, A. L. Frelinger III, and A. D. Michelson Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2319 - 2325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Andrade, M. Wessendarp, and C. S. Subauste CD154 Activates Macrophage Antimicrobial Activity in the Absence of IFN-{gamma} through a TNF-{alpha}-Dependent Mechanism J. Immunol., December 15, 2003; 171(12): 6750 - 6756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chougnet Role of CD40 Ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells J. Leukoc. Biol., November 1, 2003; 74(5): 702 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Park, A. R. Thomsen, C. W. Frevert, U. Pham, S. J. Skerrett, P. A. Kiener, and W. C. Liles Fas (CD95) Induces Proinflammatory Cytokine Responses by Human Monocytes and Monocyte-Derived Macrophages J. Immunol., June 15, 2003; 170(12): 6209 - 6216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Varo, D. Vicent, P. Libby, R. Nuzzo, A. L. Calle-Pascual, M. R. Bernal, A. Fernandez-Cruz, A. Veves, P. Jarolim, J. J. Varo, et al. Elevated Plasma Levels of the Atherogenic Mediator Soluble CD40 Ligand in Diabetic Patients: A Novel Target of Thiazolidinediones Circulation, June 3, 2003; 107(21): 2664 - 2669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Gold, M. Parsey, Y. Hoshino, S. Hoshino, A. Nolan, H. Yee, D. B. Tse, and M. D. Weiden CD40 Contributes to Lethality in Acute Sepsis: In Vivo Role for CD40 in Innate Immunity Infect. Immun., June 1, 2003; 71(6): 3521 - 3528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Inwald, A. McDowall, M. J. Peters, R. E. Callard, and N. J. Klein CD40 Is Constitutively Expressed on Platelets and Provides a Novel Mechanism for Platelet Activation Circ. Res., May 16, 2003; 92(9): 1041 - 1048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Nannizzi-Alaimo, V. L. Alves, and D. R. Phillips Inhibitory Effects of Glycoprotein IIb/IIIa Antagonists and Aspirin on the Release of Soluble CD40 Ligand During Platelet Stimulation Circulation, March 4, 2003; 107(8): 1123 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kiriakidis, E. Andreakos, C. Monaco, B. Foxwell, M. Feldmann, and E. Paleolog VEGF expression in human macrophages is NF-{kappa}B-dependent: studies using adenoviruses expressing the endogenous NF-{kappa}B inhibitor I{kappa}B{alpha} and a kinase-defective form of the I{kappa}B kinase 2 J. Cell Sci., February 15, 2003; 116(4): 665 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. O. Lee, L. Haynes, S. M. Eaton, S. L. Swain, and T. D. Randall The Biological Outcome of CD40 Signaling Is Dependent on the Duration of CD40 Ligand Expression: Reciprocal Regulation by Interleukin (IL)-4 and IL-12 J. Exp. Med., September 2, 2002; 196(5): 693 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Larkin, C. D. Benjamin, Y.-M. Hsu, Q. Li, L. Zukowski, and R. F. Silver CD40 Ligand (CD154) Does Not Contribute to Lymphocyte-Mediated Inhibition of Virulent Mycobacterium tuberculosis within Human Monocytes Infect. Immun., August 1, 2002; 70(8): 4716 - 4720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Abe, Y. Shintani, Y. Eto, K. Harada, M. Kosaka, and T. Matsumoto Potent induction of activin A secretion from monocytes and bone marrow stromal fibroblasts by cognate interaction with activated T cells J. Leukoc. Biol., August 1, 2002; 72(2): 347 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Nannizzi-Alaimo, M. H. Rubenstein, V. L. Alves, G. Y. Leong, D. R. Phillips, and H. K. Gold Cardiopulmonary Bypass Induces Release of Soluble CD40 Ligand Circulation, June 18, 2002; 105(24): 2849 - 2854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Companjen, L. I. v. d. Wel, L. Boon, E. P. Prens, and J. D. Laman CD40 ligation-induced cytokine production in human skin explants is partly mediated via IL-1 Int. Immunol., June 1, 2002; 14(6): 669 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wittmann, P. Kienlin, S. Mommert, A. Kapp, and T. Werfel Suppression of IL-12 Production by Soluble CD40 Ligand: Evidence for Involvement of the p44/42 Mitogen-Activated Protein Kinase Pathway J. Immunol., April 15, 2002; 168(8): 3793 - 3800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Iwata, K. Soya, M. Sawa, T. Sakimoto, and D. G. Hwang CD40 Expression in Normal Human Cornea and Regulation of CD40 in Cultured Human Corneal Epithelial and Stromal Cells Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 348 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Lobo, P. R. Scholl, and R. L. Fuleihan CD40 Ligand-Deficient T Cells from X-Linked Hyper-IgM Syndrome Carriers Have Intrinsic Priming Capability J. Immunol., February 1, 2002; 168(3): 1473 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Luft, M. Jefford, P. Luetjens, H. Hochrein, K.-A. Masterman, C. Maliszewski, K. Shortman, J. Cebon, and E. Maraskovsky IL-1{beta} Enhances CD40 Ligand-Mediated Cytokine Secretion by Human Dendritic Cells (DC): A Mechanism for T Cell-Independent DC Activation J. Immunol., January 15, 2002; 168(2): 713 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Schonbeck and P. Libby CD40 Signaling and Plaque Instability Circ. Res., December 7, 2001; 89(12): 1092 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Warwick-Davies, A. J. Watson, G. E. Griffin, S. Krishna, and R. J. Shattock Enhancement of Mycobacterium tuberculosis-Induced Tumor Necrosis Factor Alpha Production from Primary Human Monocytes by an Activated T-Cell Membrane-Mediated Mechanism Infect. Immun., November 1, 2001; 69(11): 6580 - 6587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Baram, G. G. Vaday, P. Salamon, I. Drucker, R. Hershkoviz, and Y. A. Mekori Human Mast Cells Release Metalloproteinase-9 on Contact with Activated T Cells: Juxtacrine Regulation by TNF-{alpha} J. Immunol., October 1, 2001; 167(7): 4008 - 4016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Salih, H. M. Schmetzer, C. Burke, G. C. Starling, R. Dunn, R. Pelka-Fleischer, V. Nuessler, and P. A. Kiener Soluble CD137 (4-1BB) Ligand Is Released Following Leukocyte Activation and Is Found in Sera of Patients with Hematological Malignancies J. Immunol., October 1, 2001; 167(7): 4059 - 4066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Henn, S. Steinbach, K. Buchner, P. Presek, and R. A. Kroczek The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40 Blood, August 15, 2001; 98(4): 1047 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Novak, T. Bieber, and N. Katoh Engagement of Fc{{epsilon}}RI on Human Monocytes Induces the Production of IL-10 and Prevents Their Differentiation in Dendritic Cells J. Immunol., July 15, 2001; 167(2): 797 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Liles, A. R. Thomsen, D. S. O'Mahony, and S. J. Klebanoff Stimulation of human neutrophils and monocytes by staphylococcal phenol-soluble modulin J. Leukoc. Biol., July 1, 2001; 70(1): 96 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Pekkari, J. Avila-Carino, A. Bengtsson, R. Gurunath, A. Scheynius, and A. Holmgren Truncated thioredoxin (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes Blood, May 15, 2001; 97(10): 3184 - 3190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Pearson, B. E. Castle, and M. R. Kehry CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways Int. Immunol., March 1, 2001; 13(3): 273 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. I. Brodskyn, G. K. DeKrey, and R. G. Titus Influence of Costimulatory Molecules on Immune Response to Leishmania major by Human Cells In Vitro Infect. Immun., February 1, 2001; 69(2): 665 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Molano, T. Berney, H. Li, P. Cattan, A. Pileggi, C. Vizzardelli, N. S. Kenyon, C. Ricordi, L. C. Burkly, and L. Inverardi Prolonged Islet Graft Survival in NOD Mice by Blockade of the CD40-CD154 Pathway of T-Cell Costimulation Diabetes, February 1, 2001; 50(2): 270 - 276. [Abstract] [Full Text]
|
|
|
|
|
|
L. M. Howard and S. D. Miller Autoimmune Intervention by CD154 Blockade Prevents T Cell Retention and Effector Function in the Target Organ J. Immunol., February 1, 2001; 166(3): 1547 - 1553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Storz, K. Zepter, J. Kamarashev, R. Dummer, G. Burg, and A. C. Häffner Coexpression of CD40 and CD40 Ligand in Cutaneous T-Cell Lymphoma (Mycosis Fungoides) Cancer Res., January 1, 2001; 61(2): 452 - 454. [Abstract] [Full Text]
|
|
|
|
|
|
D. M. Rothstein, M. F. A. Livak, K. Kishimoto, C. Ariyan, H.-Y. Qian, S. Fecteau, M. Sho, S. Deng, X. X. Zheng, M. H. Sayegh, et al. Targeting Signal 1 Through CD45RB Synergizes with CD40 Ligand Blockade and Promotes Long Term Engraftment and Tolerance in Stringent Transplant Models J. Immunol., January 1, 2001; 166(1): 322 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Mehlhop, M. van de Rijn, J. P. Brewer, A. B. Kisselgof, R. S. Geha, H. C. Oettgen, and T. R. Martin CD40L, but Not CD40, Is Required for Allergen-Induced Bronchial Hyperresponsiveness in Mice Am. J. Respir. Cell Mol. Biol., November 1, 2000; 23(5): 646 - 651. [Abstract] [Full Text]
|
|
|
|
|
|
F. Willermain, L. Caspers–Velu, N. Baudson, C. Dubois, M. Hamdane, F. Willems, T. Velu, and C. Bruyns Role and Expression of CD40 on Human Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3485 - 3491. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Zhan, A. J. Corbett, J. L. Brady, R. M. Sutherland, and A. M. Lew CD4 Help-Independent Induction of Cytotoxic CD8 Cells to Allogeneic P815 Tumor Cells Is Absolutely Dependent on Costimulation J. Immunol., October 1, 2000; 165(7): 3612 - 3619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Yamauchi, J. R. Bleharski, K. Uyemura, J. Kim, P. A. Sieling, A. Miller, H. Brightbill, K. Schlienger, T. H. Rea, and R. L. Modlin A Role for CD40-CD40 Ligand Interactions in the Generation of Type 1 Cytokine Responses in Human Leprosy J. Immunol., August 1, 2000; 165(3): 1506 - 1512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dybul, G. Mercier, M. Belson, C. W. Hallahan, S. Liu, C. Perry, B. Herpin, L. Ehler, R. T. Davey, J. A. Metcalf, et al. CD40 Ligand Trimer and IL-12 Enhance Peripheral Blood Mononuclear Cells and CD4+ T Cell Proliferation and Production of IFN-{gamma} in Response to p24 Antigen in HIV-Infected Individuals: Potential Contribution of Anergy to HIV-Specific Unresponsiveness J. Immunol., August 1, 2000; 165(3): 1685 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Schonbeck, G. K. Sukhova, K. Shimizu, F. Mach, and P. Libby Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice PNAS, June 20, 2000; 97(13): 7458 - 7463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Solanilla, J. Dechanet, A. El Andaloussi, M. Dupouy, F. Godard, J. Chabrol, P. Charbord, J. Reiffers, A. T. Nurden, B. Weksler, et al. CD40-ligand stimulates myelopoiesis by regulating flt3-ligand and thrombopoietin production in bone marrow stromal cells Blood, June 15, 2000; 95(12): 3758 - 3764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-S. Cho, M.-L. Cho, S.-Y. Min, W.-U. Kim, D.-J. Min, S.-S. Lee, S.-H. Park, J. Choe, and H.-Y. Kim CD40 Engagement on Synovial Fibroblast Up-Regulates Production of Vascular Endothelial Growth Factor J. Immunol., May 15, 2000; 164(10): 5055 - 5061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Schonbeck, F. Mach, G. K. Sukhova, M. Herman, P. Graber, M. R. Kehry, and P. Libby CD40 Ligation Induces Tissue Factor Expression in Human Vascular Smooth Muscle Cells Am. J. Pathol., January 1, 2000; 156(1): 7 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Perlman, L. J. Pagliari, C. Georganas, T. Mano, K. Walsh, and R. M. Pope FLICE-inhibitory Protein Expression during Macrophage Differentiation Confers Resistance to Fas-mediated Apoptosis J. Exp. Med., December 6, 1999; 190(11): 1679 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Lorenzen, F. Dux, U. Wolk, A. Tsirpouchtsidis, G. Haas, and T. F. Meyer Immunoglobulin A1 Protease, an Exoenzyme of Pathogenic Neisseriae, Is a Potent Inducer of Proinflammatory Cytokines J. Exp. Med., October 18, 1999; 190(8): 1049 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Marriott, E. K. Thomas, and K. L. Bost CD40-CD40 Ligand Interactions Augment Survival of Normal Mice, but Not CD40 Ligand Knockout Mice, Challenged Orally with Salmonella dublin Infect. Immun., October 1, 1999; 67(10): 5253 - 5257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Liu, S. Colpaert, G. R. D'Haens, A. Kasran, M. d. Boer, P. Rutgeerts, K. Geboes, and J. L. Ceuppens Hyperexpression of CD40 Ligand (CD154) in Inflammatory Bowel Disease and Its Contribution to Pathogenic Cytokine Production J. Immunol., October 1, 1999; 163(7): 4049 - 4057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Whitmire, R. A. Flavell, I. S. Grewal, C. P. Larsen, T. C. Pearson, and R. Ahmed CD40-CD40 Ligand Costimulation Is Required for Generating Antiviral CD4 T Cell Responses But Is Dispensable for CD8 T Cell Responses J. Immunol., September 15, 1999; 163(6): 3194 - 3201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hagimoto, K. Kuwano, M. Kawasaki, M. Yoshimi, Y. Kaneko, R. Kunitake, T. Maeyama, T. Tanaka, and N. Hara Induction of Interleukin-8 Secretion and Apoptosis in Bronchiolar Epithelial Cells by Fas Ligation Am. J. Respir. Cell Mol. Biol., September 1, 1999; 21(3): 436 - 445. [Abstract] [Full Text]
|
|
|
